Clinical Efficacy of Telemedicine Compared to Face-to-Face Clinic Visits for Smoking Cessation: Multicenter Open-Label Randomized Controlled Noninferiority Trial
Akihiro Nomura(Kanazawa University), Kohta Satake(Osaka City University), Eisuke Hida(The University of Osaka), Arihiro Kiyosue, Takafumi Oga, Tomoyuki Tanigawa(St. Luke's International University), Tomoyasu Muto, Masaki Miyazaki(Suita Municipal Hospital), Yasushi Fukushima(Fukuda Denshi (Japan))
Cited by 77
Related Papers
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial
|The Lancet Oncology|2019|642
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes
|Diabetes Care|2019|465
14-3-3 Protein Binds to Insulin Receptor Substrate-1, One of the Binding Sites of Which Is in the Phosphotyrosine Binding Domain
|Journal of Biological Chemistry|1997|175
Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease
|Journal of clinical lipidology|2018|115
A randomized controlled trial of a smoking cessation smartphone application with a carbon monoxide checker
|npj Digital Medicine|2020|112